CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells

키워드

참고문헌 (147)

1. Collins FS, "A new initiative on precision medicine", N Engl J Med, 372, pp.793~795 (2015)
2. Lander ES., "Cutting the Gordian helix: regulating genomic testing in the era of precision medicine", N Engl J Med, 372, pp.1185~1186 (2015)
3. Jameson JL, "Precision medicine: personalized, problematic, and promising", N Engl J Med, 372, pp.2229~2234 (2015)
4. Barrangou R, "CRISPR provides acquired resistance against viruses in prokaryotes", Science, 315, pp.1709~1712 (2007)
5. Ishino Y, "Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product", J Bacteriol, 169, pp.5429~5433 (1987)
6. Bolotin A, "Clustered regularly interspaced short palindrome repeats (CRISPRs)have spacers of extrachromosomal origin", Microbiology, 151(Pt 8), pp.2551~2561 (2005)
7. Mojica FJ, "Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements", J Mol Evol, 60, pp.174~182 (2005)
8. Pourcel C, "CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies", Microbiology, 151(Pt 3), pp.653~663 (2005)
9. Marraffini LA, "CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA", Science, 322, pp.1843~1845 (2008)
10. Hale CR, "RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex", Cell, 139, pp.945~956 (2009)
11. Brouns SJ, "Small CRISPR RNAs guide antiviral defense in prokaryotes", Science, 321, pp.960~964 (2008)
12. Jinek M, "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science, 337, pp.816~821 (2012)
13. Cong L, "Multiplex genome engineering using CRISPR", Cas systems, 2013, pp.339, 819~823
14. Mali P, "RNA-guided human genome engineering via Cas9", Science, 339, pp.823~826 (2013)
15. Mojica FJ, "Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria", Mol Microbiol, 36, pp.244~246 (2000)
16. Jansen R, "Identification of genes that are associated with DNA repeats in prokaryotes", Mol Microbiol, 43, pp.1565~1575 (2002)
17. Makarova KS, "A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis", Nucleic Acids Res, 30, pp.482~496 (2002)
18. Haft DH, "A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR", Cas subtypes exist in prokaryotic genomes, 2005, pp.1, e60~
19. Garneau JE, "The CRISPR", Cas bacterial immune system cleaves bacteriophage and plasmid DNA, 2010, pp.468, 67~71
20. Deltcheva E, "CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III", Nature, 471, pp.602~607 (2011)
21. Sapranauskas R, "The Streptococcus thermophilus CRISPR", Cas system provides immunity in Escherichia coli, 2011, pp.39, 9275~9282
22. Jinek M, "RNAprogrammed genome editing in human cells", Elife, 2, pp.e00471~ (2013)
23. Hwang WY, "Efficient genome editing in zebrafish using a CRISPR-Cas system", Nat Biotechnol, 31, pp.227~229 (2013)
24. Wang H, "One-step generation of mice carrying mutations in multiple genes by CRISPR", Cas-mediated genome engineering, 2013, pp.153, 910~918
25. Bassett AR, "Highly efficient targeted mutagenesis of Drosophila with the CRISPR", Cas9 system, 2013, pp.4, 220~228
26. Friedland AE, "Heritable genome editing in C. elegans via a CRISPR-Cas9 system", Nat Methods, 10, pp.741~743 (2013)
27. Li JF, "Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9", Nat Biotechnol, 31, pp.688~691 (2013)
28. Nakayama T, "Simple and efficient CRISPR", Cas9-mediated targeted mutagenesis in Xenopus tropicalis, 2013, pp.51, 835~843
29. Jinek M, "Structures of Cas9 endonucleases reveal RNA-mediated conformational activation", Science, 343, pp.1247997~ (2014)
30. Nishimasu H, "Crystal structure of Cas9 in complex with guide RNA and target DNA", Cell, 156, pp.935~949 (2014)
31. Wang T, "Genetic screens in human cells using the CRISPR-Cas9 system", Science, 343, pp.80~84 (2014)
32. Shalem O, "Genome-scale CRISPR-Cas9 knockout screening in human cells", Science, 343, pp.84~87 (2014)
33. Niu Y, "Generation of gene-modified cynomolgus monkey via Cas9", RNA-mediated gene targeting in one-cell embryos, 2014, pp.156, 836~843
34. Wagner JC, "Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum", Nat Methods, 11, pp.915~918 (2014)
35. Liang P, "CRISPR", Cas9-mediated gene editing in human tripronuclear zygotes, 2015, pp.6, 363~372
36. Cleto S, "Corynebacterium glutamicum metabolic engineering with CRISPR interference (CRISPRi)", ACS Synth Biol, 5, pp.375~385 (2016)
37. Wright AV, "Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering", Cell, 164, pp.29~44 (2016)
38. Shmakov S, "Discovery and functional characterization of diverse class 2 CRISPR-Cas systems", Mol Cell, 60, pp.385~397 (2015)
39. Doudna JA, "Genome editing: the new frontier of genome engineering with CRISPR-Cas9", Science, 346, pp.1258096~ (2014)
40. Makarova KS, "Evolution and classification of the CRISPR-Cas systems", Nat Rev Microbiol, 9, pp.467~477 (2011)
41. Makarova KS, "An updated evolutionary classification of CRISPR-Cas systems", Nat Rev Microbiol, 13, pp.722~736 (2015)
42. Lander ES., "The heroes of CRISPR", Cell, 164, pp.18~28 (2016)
43. Charpentier E, "Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity", FEMS Microbiol Rev, 39, pp.428~441 (2015)
44. Kim H, "A guide to genome engineering with programmable nucleases", Nat Rev Genet, 15, pp.321~334 (2014)
45. Charpentier E, "Biotechnology: rewriting a genome", Nature, 495, pp.50~51 (2013)
46. Cox DB, "Therapeutic genome editing:prospects and challenges", Nat Med, 21, pp.121~131 (2015)
47. Silva G, "Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy", Curr Gene Ther, 11, pp.11~27 (2011)
48. Urnov FD, "Genome editing with engineered zinc finger nucleases", Nat Rev Genet, 11, pp.636~646 (2010)
49. Christian M, "Targeting DNA double-strand breaks with TAL effector nucleases", Genetics, 186, pp.757~761 (2010)
50. Maeder ML, "Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification", Mol Cell, 31, pp.294~301 (2008)
51. Moscou MJ, "A simple cipher governs DNA recognition by TAL effectors", Science, 326, pp.1501~ (2009)
52. Joung JK, "TALENs: a widely applicable technology for targeted genome editing", Nat Rev Mol Cell Biol, 14, pp.49~55 (2013)
53. Prakash V, "Current progress in therapeutic gene editing for monogenic diseases", Mol Ther, 24, pp.465~474 (2016)
54. Ousterout DG, "Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients", Mol Ther, 21, pp.1718~1726 (2013)
55. Benabdallah BF, "Targeted gene addition of microdystrophin in mice skeletal muscle via human myoblast transplantation", Mol Ther Nucleic Acids, 2, pp.e68~ (2013)
56. Ousterout DG, "Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases", Mol Ther, 23, pp.523~532 (2015)
57. Ousterout DG, "Multiplex CRISPR", Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy, 2015, pp.6, 6244~
58. Voit RA, "Nuclease-mediated gene editing by homologous recombination of the human globin locus", Nucleic Acids Res, 42, pp.1365~1378 (2014)
59. Hu W, "RNA-directed gene editing specifically eradicates latent and prevents new HIV-1infection", Proc Natl Acad Sci U S A, 111, pp.11461~11466 (2014)
60. Lin SR, "The CRISPR", Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo, 2014, pp.3, e186~
61. Kennedy EM, "Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR", Cas RNA-guided DNA endonuclease, 2015, pp.476, 196~205
62. Seeger C, "Targeting hepatitis B virus with CRISPR", Cas9, 2014, pp.3, e216~
63. Ramanan V, "CRISPR", Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus, 2015, pp.5, 10833~
64. Zhen S, "Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)", CRISPR-associated Cas9 system to disrupt the hepatitis B virus, 2015, pp.22, 404~412
65. Dong C, "Targeting hepatitis B virus cccDNA by CRISPR", Cas9 nuclease efficiently inhibits viral replication, 2015, pp.118, 110~117
66. Liu X, "Inhibition of hepatitis B virus by the CRISPR", Cas9 system via targeting the conserved regions of the viral genome, 2015, pp.96, 2252~2261
67. Zhen S, "In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR", Cas9, 2014, pp.450, 1422~1426
68. Kennedy EM, "Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR", Cas RNA-guided endonuclease, 2014, pp.88, 11965~11972
69. Yu L, "Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat", Cas system in human cervical cancer cells, 2015, pp.8, 37~44
70. Hu Z, "Disruption of HPV16-E7 by CRISPR", Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells, 2014, pp.2014, 612823~
71. Lee CM, "Correction of the deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator gene by zinc-finger nuclease homology-directed repair", Biores Open Access, 1, pp.99~108 (2012)
72. Li XB, "Zinc finger protein HZF1 promotes K562 cell proliferation by interacting with and inhibiting INCA1", Mol Med Rep, 4, pp.1131~1137 (2011)
73. Lombardo A, "Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery", Nat Biotechnol, 25, pp.1298~1306 (2007)
74. Urnov FD, "Highly efficient endogenous human gene correction using designed zinc-finger nucleases", Nature, 435, pp.646~651 (2005)
75. Matsubara Y, "Transcription activator-like effector nuclease-mediated transduction of exogenous gene into IL2RG locus", Sci Rep, 4, pp.5043~ (2014)
76. Genovese P, "Targeted genome editing in human repopulating haematopoietic stem cells", Nature, 510, pp.235~240 (2014)
77. Osborn MJ, "TALEN-based gene correction for epidermolysis bullosa", Mol Ther, 21, pp.1151~1159 (2013)
78. Nelson CE, "In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy", Science, 351, pp.403~407 (2016)
79. Tabebordbar M, "In vivo gene editing in dystrophic mouse muscle and muscle stem cells", Science, 351, pp.407~411 (2016)
80. Long C, "Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy", Science, 351, pp.400~403 (2016)
81. Wu Y, "Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells", Cell Res, 25, pp.67~79 (2015)
82. Li H, "In vivo genome editing restores haemostasis in a mouse model of haemophilia", Nature, 475, pp.217~221 (2011)
83. Anguela XM, "Robust ZFN-mediated genome editing in adult hemophilic mice", Blood, 122, pp.3283~3287 (2013)
84. Sharma R, "In vivo genome editing of the albumin locus as a platform for protein replacement therapy", Blood, 126, pp.1777~1784 (2015)
85. Yin H, "Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype", Nat Biotechnol, 32, pp.551~553 (2014)
86. Long C, "Prevention of muscular dystrophy in mice by CRISPR", Cas9-mediated editing of germline DNA, 2014, pp.345, 1184~1188
87. Xu L, "CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice", Mol Ther, 24, pp.564~569 (2016)
88. Ding Q, "Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing", Circ Res, 115, pp.488~492 (2014)
89. Li HL, "Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9", Stem Cell Reports, 4, pp.143~154 (2015)
90. Park CY, "Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs", Proc Natl Acad Sci U S A, 111, pp.9253~9258 (2014)
91. Park CY, "Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9", Cell Stem Cell, 17, pp.213~220 (2015)
92. Hoban MD, "Correction of the sickle cell disease mutation in human hematopoietic stem", progenitor cells, 2015, pp.125, 2597~2604
93. Sebastiano V, "In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases", Stem Cells, 29, pp.1717~1726 (2011)
94. Sun N, "Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs", Biotechnol Bioeng, 111, pp.1048~1053 (2014)
95. Huang X, "Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation", Stem Cells, 33, pp.1470~1479 (2015)
96. Xie F, "Seamless gene correction of beta-thalassemia mutations in patient-specific iPSCs using CRISPR", Cas9 and piggyBac, 2014, pp.24, 1526~1533
97. Ma N, "Factor-induced reprogramming and zinc finger nuclease-aided gene targeting cause different genome instability in beta-thalassemia induced pluripotent stem cells (iPSCs)", J Biol Chem, 290, pp.12079~12089 (2015)
98. Ye L, "Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Delta32 mutation confers resistance to HIV infection", Proc Natl Acad Sci U S A, 111, pp.9591~9596 (2014)
99. Wilen CB, "Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases", PLoS Pathog, 7, pp.e1002020~ (2011)
100. Sebastiano V, "Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa", Sci Transl Med, 6, pp.264ra163~ (2014)
101. Crane AM, "Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells", Stem Cell Reports, 4, pp.569~577 (2015)
102. Sargent RG, "Nuclease-mediated double-strand break (DSB) enhancement of small fragment homologous recombination (SFHR) gene modification in human-induced pluripotent stem cells (hiPSCs)", Methods Mol Biol, 1114, pp.279~290 (2014)
103. Firth AL, "Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs", Cell Rep, 12, pp.1385~1390 (2015)
104. Schwank G, "Functional repair of CFTR by CRISPR", Cas9 in intestinal stem cell organoids of cystic fibrosis patients, 2013, pp.13, 653~658
105. Suzuki S, "TALENs facilitate single-step seamless SDF correction of F508del CFTR in airway epithelial submucosal gland cell-derived CF-iPSCs", Mol Ther Nucleic Acids, 5, pp.e273~ (2016)
106. Vierstra J, "Functional footprinting of regulatory DNA", Nat Methods, 12, pp.927~930 (2015)
107. Canver MC, "BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis", Nature, 527, pp.192~197 (2015)
108. Rahman SH, "Rescue of DNAPK signaling and T-cell differentiation by targeted genome editing in a prkdc deficient iPSC disease model", PLoS Genet, 11, pp.e1005239~ (2015)
109. Menon T, "Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs", Cell Stem Cell, 16, pp.367~372 (2015)
110. Holt N, "Human hematopoietic stem", progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo, 2010, pp.28, 839~847
111. Li L, "Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases", Mol Ther, 21, pp.1259~1269 (2013)
112. Nathwani AC, "Adenovirus-associated virus vector-mediated gene transfer in hemophilia B", N Engl J Med, 365, pp.2357~2365 (2011)
113. Nathwani AC, "Longterm safety and efficacy of factor IX gene therapy in hemophilia B", N Engl J Med, 371, pp.1994~2004 (2014)
114. Hutter G, "Long-term control of HIV by CCR5 Delta32", Delta32 stem-cell transplantation, 2009, pp.360, 692~698
115. Tebas P, "Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV", N Engl J Med, 370, pp.901~910 (2014)
116. Badia R, "Zinc finger endonuclease targeting PSIP1 inhibits HIV-1 integration", Antimicrob Agents Chemother, 58, pp.4318~4327 (2014)
117. Fadel HJ, "TALEN knockout of the PSIP1 gene in human cells: analyses of HIV-1 replication and allosteric integrase inhibitor mechanism", J Virol, 88, pp.9704~9717 (2014)
118. White MK, "CRISPR", Cas9 and cancer targets:future possibilities and present challenges, 2016, pp.7, 12305~12317
119. Brown MT, "Regulation, substrates and functions of src", Biochim Biophys Acta, 1287, pp.121~149 (1996)
120. Choi PS, "Targeted genomic rearrangements using CRISPR", Cas technology, 2014, pp.5, 3728~
121. Chen C, "MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia", Cancer Cell, 25, pp.652~665 (2014)
122. Xue W, "CRISPR-mediated direct mutation of cancer genes in the mouse liver", Nature, 514, pp.380~384 (2014)
123. Chiou SH, "Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR", Cas9-mediated somatic genome editing, 2015, pp.29, 1576~1585
124. Tu Z, "CRISPR", Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases, 2015, pp.10, 35~
125. Hsu PD, "Development and applications of CRISPR-Cas9 for genome engineering", Cell, 157, pp.1262~1278 (2014)
126. Jusiak B, "Engineering synthetic gene circuits in living cells with CRISPR technology", Trends Biotechnol, 34, pp.535~547 (2016)
127. Wang Y, "Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew", Nat Biotechnol, 32, pp.947~951 (2014)
128. Zhou Y, "High-throughput screening of a CRISPR", Cas9 library for functional genomics in human cells, 2014, pp.509, 487~491
129. Sebastian Diecke, "Recent technological updates and clinical applications of induced pluripotent stem cells", The Korean Journal of Internal Medicine, 29(5), pp.547~557 (2014), 대한내과학회[DOI]
130. Musunuru K., "Genome editing of human pluripotent stem cells to generate human cellular disease models", Dis Model Mech, 6, pp.896~904 (2013)
131. Grobarczyk B, "Generation of isogenic human iPS cell line precisely corrected by genome editing using the CRISPR", Cas9 system, 2015, pp.11, 774~787
132. Orqueda AJ, "iPSCs: a minireview from bench to bed, including organoids and the CRISPR system", Stem Cells Int, 2016, pp.5934782~ (2016)
133. Maruyama T, "Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining", Nat Biotechnol, 33, pp.538~542 (2015)
134. Chu VT, "Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells", Nat Biotechnol, 33, pp.543~548 (2015)
135. Nakade S, "Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR", Cas9, 2014, pp.5, 5560~
136. Sakuma T, "MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems", Nat Protoc, 11, pp.118~133 (2016)
137. Ledford H., "Bacteria yield new gene cutter", Nature, 526, pp.17~ (2015)
138. Hsu PD, "DNA targeting specificity of RNA-guided Cas9 nucleases", Nat Biotechnol, 31, pp.827~832 (2013)
139. Mali P, "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering", Nat Biotechnol, 31, pp.833~838 (2013)
140. Ran FA, "Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity", Cell, 154, pp.1380~1389 (2013)
141. Fu Y, "Improving CRISPR-Cas nuclease specificity using truncated guide RNAs", Nat Biotechnol, 32, pp.279~284 (2014)
142. Guilinger JP, "Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification", Nat Biotechnol, 32, pp.577~582 (2014)
143. Tsai SQ, "Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing", Nat Biotechnol, 32, pp.569~576 (2014)
144. Hastie E, "Adeno-associated virus at 50:a golden anniversary of discovery, research, and gene therapy success: a personal perspective", Hum Gene Ther, 26, pp.257~265 (2015)
145. Moore R, "CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells", Nucleic Acids Res, 43, pp.1297~1303 (2015)
146. Kormann MS, "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice", Nat Biotechnol, 29, pp.154~157 (2011)
147. Zuris JA, "Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo", Nat Biotechnol, 33, pp.73~80 (2015)

관련 논문AI추천